SEC Filings

Filing Description Date Filed Sorted Descending Size  
8-K current report Jul 8, 2010 20.5 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Jun 18, 2010 32.1 KB Add to Briefcase
424B5 prospectus filed pursuant to rule 424 Jun 4, 2010 448.0 KB Add to Briefcase
8-K current report Jun 3, 2010 94.1 KB Add to Briefcase
EFFECT effectiveness order Jun 2, 2010 0.0 KB  
8-K current report Jun 1, 2010 20.7 KB Add to Briefcase
8-K current report May 25, 2010 23.0 KB Add to Briefcase
8-K current report May 20, 2010 275.9 KB Add to Briefcase
424B5 prospectus filed pursuant to rule 424 May 20, 2010 448.7 KB Add to Briefcase
S-3 registration statement May 20, 2010 362.9 KB Add to Briefcase
10-Q quarterly report May 13, 2010 484.0 KB Add to Briefcase
8-K current report May 13, 2010 69.5 KB Add to Briefcase
4 ekman, lars May 3, 2010 18.9 KB Add to Briefcase
4 leonard, keith r May 3, 2010 19.0 KB Add to Briefcase
4 rosenman, herm May 3, 2010 18.9 KB Add to Briefcase
4 simon, nicholas j iii May 3, 2010 19.0 KB Add to Briefcase
4 sekhri, paul j May 3, 2010 18.9 KB Add to Briefcase
4 beier, david w May 3, 2010 18.9 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Apr 20, 2010 1.7 MB Add to Briefcase
DEF 14A definitive proxy statement Apr 16, 2010 531.2 KB Add to Briefcase
Showing 1-20 of 193 Page: 1 2 3 ... 10  Next 20
Add to Briefcase = add filing to Briefcase
Stock Information
NASDAQ:ARYX
$0.46   - 0.02
Jul 29, 2010
3:33 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
 ARYx Therapeutics Final
     Prospectus

Corporate Presentation

Learn more about our products, technology, and financial history by viewing our Corporate Presentation.

Learn More